Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A design for phase I trials in completely or partially ordered groups.

Mark R Conaway1

  • 1Department of Public Health Sciences, University of Virginia Health System, P.O. Box 800717, Charlottesville, 22908, VA, U.S.A.

Statistics in Medicine
|April 7, 2017
PubMed
Summary

This study introduces a novel dose-finding design for cytotoxic drugs, incorporating patient group ordering to optimize toxicity probability assessment. The method enhances clinical trial efficiency by integrating parametric models with order-restricted estimation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preterm Birth Increases Susceptibility to Hyperglycemia-Induced Kidney Injury With Sex-Specific Differences in Structural and Molecular Responses.

Endocrinology, diabetes & metabolism·2026
Same author

PREDICT-ITB: Predicting response in children with dystonic CP to ITB - study protocol.

medRxiv : the preprint server for health sciences·2025
Same author

Semilunar Valve Function After Rejection in Heart Transplant Recipients: Implications for Partial Heart Transplantation.

Pediatric transplantation·2025
Same author

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies.

PloS one·2023

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacology

Background:

  • Dose-finding studies are crucial for determining optimal cytotoxic agent levels.
  • Existing methods may not fully leverage pre-existing clinical knowledge about patient group toxicity.
  • Ordering patient groups by toxicity probability can improve dose selection.

Purpose of the Study:

  • To propose a new dose-finding design for cytotoxic agents.
  • To accommodate both completely and partially ordered patient groups.
  • To enhance the precision of dose-toxicity relationship estimation.

Main Methods:

  • Combines parametric modeling from the continual reassessment method.
  • Integrates the Hwang-Peddada order-restricted estimation procedure.
Keywords:
cytotoxic agentdose findingheterogeneous groups

Related Experiment Videos

  • Evaluates operating characteristics using simulated dose-toxicity curves.

    • Main Results:

    • The proposed design effectively handles completely and partially ordered patient groups.
    • Demonstrates robust performance across various dose-toxicity scenarios.
    • Provides a framework for more informed dose selection in clinical trials.

    Conclusions:

    • The novel design offers an effective approach for dose finding with ordered patient groups.
    • This method improves upon existing strategies by incorporating order restrictions.
    • Facilitates more efficient and precise determination of cytotoxic agent doses.